NEW YORK, Aug. 30 – Galapagos Genomics and the Flanders Interuniversity Institute for Biotechnology have entered a collaboration to identify and validate Alzheimer-related gene targets, the companies announced Thursday.

Under the terms of the collaboration, Galapagos, a privately held company based in Belgium, integrate its PhenoSelect gene function discovery platform with the Flanders Interuniversity Institute for Biotechnology’s (VIB) cell-based presesilin-gamma-secretase assays to screen its human gene library for genes involved in Alzheimer’s Disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.